Re-Mind contains low-dose Lithium Orotate and Fulvic Acid. Research indicates that lithium levels in the brain may decline with age and in conditions like mild cognitive impairment and Alzheimer’s disease. Lithium orotate, as used in Re-Mind, is suggested to help prevent synapse loss, tau accumulation, and cognitive decline in animal models, aligning with strategies for age-related cognitive maintenance.